A very strong cross-talk mechanism has been identified due to the observation that upregulation of mTORC1 activity in tumours derived from TSC patients and in cells lacking Tsc2 is accompanied by downregulation of Akt [110-114]. This evidence concerns the gene TSC2 and tuberous sclerosis.